Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: A systematic review and meta-analysis

被引：0
|
作者：
Omori, Reo
Fujiwara, Yu
Tokunaga, Kota
Sato, Takumi
Mukherjee, Sarbajit
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[3] Nagoya Univ, Sch Med, Nagoya, Japan
[4] Univ Tokyo Hosp, Dept Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [1] Perioperative FLOT plus immunotherapy for resectable gastric and gastroesophageal junction cancer: A systematic review and meta-analysis
    Revillas, L. F. E.
    Lalusis, J. K. M.
    Dy, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1478 - S1478
  • [2] Efficacy and Safety of Sintilimab in Patients With Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis
    Altaf, Faryal
    Fatima, Eeshal
    Khanzada, Mikail
    Safi, Adnan
    Qureshi, Zaheer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1679 - S1679
  • [3] Efficacy and safety of pembrolizumab in advanced gastric and gastroesophageal junction cancer: a systematic review and meta-analysis
    Ji, Xiaoying
    Wang, Guoping
    Pan, Dandan
    Xu, Shanxia
    Lei, Xinming
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [4] Perioperative FLOT plus immunotherapy for resectable gastric and gastroesophageal junction cancer: A systematic review and meta-analysis.
    Revillas, Lorenz Fort Estrada
    Lalusis, John Kelvin
    Dy, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 66 - 66
  • [5] Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis
    Abderhalden, Lauren A. A.
    Wu, Ping
    Amonkar, Mayur M. M.
    Lang, Brian M. M.
    Shah, Sukrut
    Jin, Fan
    Frederickson, Andrew M. M.
    Mojebi, Ali
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (04) : 1031 - 1045
  • [6] Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis
    Lauren A. Abderhalden
    Ping Wu
    Mayur M. Amonkar
    Brian M. Lang
    Sukrut Shah
    Fan Jin
    Andrew M. Frederickson
    Ali Mojebi
    Journal of Gastrointestinal Cancer, 2023, 54 : 1031 - 1045
  • [7] Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
    Wan, Linghong
    Tian, Fanxuan
    Wang, Lei
    Hou, Yongying
    Liu, Wenkang
    Liu, Qin
    Chen, Dongfeng
    Li, Xianfeng
    Xiang, Junyv
    Qin, Zhong-Yi
    Wang, Tao
    Mao, Bijng
    Wu, Linyu
    Hu, Lu
    CELLULAR ONCOLOGY, 2024, : 2335 - 2347
  • [8] Systematic literature review and meta-analysis of clinical outcomes for previously treated patients with advanced gastric or gastroesophageal junction cancer.
    Abderhalden, Lauren
    Frederickson, Andrew
    Lang, Brain M.
    Mojebi, Ali
    Wu, Ping
    Gozman, Alexander
    Malbecq, William
    Jin, Fan
    Amonkar, Mayur
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16054 - E16054
  • [9] Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
    Chen, Cong
    Zhang, Fan
    Zhou, Ning
    Gu, Yan-Mei
    Zhang, Ya-Ting
    He, Yi-Di
    Wang, Ling
    Yang, Lu-Xi
    Zhao, Yang
    Li, Yu-Min
    ONCOIMMUNOLOGY, 2019, 8 (05):
  • [10] Efficacy and safety of ramucirumab in gastric or gastroesophageal cancer: A systematic review and meta-analysis
    Wu, Rui
    Yuan, Sijia
    Wang, Yuxuan
    Nan, Yangli
    Chen, Zixiao
    Yuan, Hong
    Wang, Zixuan
    Li, Zuojing
    Zong, Dongsheng
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)
12345